Skip to main content
Erschienen in: Clinical Oral Investigations 3/2015

01.04.2015 | Short Communication

Comparison between three different saliva substitutes in patients with hyposalivation

verfasst von: Ivana Skrinjar, Vanja Vucicevic Boras, Iva Bakale, Ana Andabak Rogulj, Vlaho Brailo, Danica Vidovic Juras, Ivan Alajbeg, Danko Velimir Vrdoljak

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of the present study was to compare the efficiency of oral spray based on thermal spring water (Buccotherm®) versus commercial saliva substitute (Xeros®) and marshmallow root on the quality of life in patients with hyposalivation.

Materials and methods

A total of 60 patients with unstimulated salivary flow rate <0.2 ml/min were randomized into three groups. In the first group, 30 patients were using Buccotherm®; in the second group, 15 patients were using Xeros®; and in the third group, 15 patients were using marshmallow root. Therapy lasted for 2 weeks; everyday, patients used one of the products four times a day. Quality of life was measured by the Croatian version of Oral Health Impact Profile 14 questionnaire, and visual analog scale was used to determine the intensity of dry mouth before and after therapy. Statistical analysis was performed by Wilcoxon signed-rank test and Kruskal-Wallis test. Standardized effect size was calculated for OHIP following treatment.

Results

Buccotherm® has shown the biggest effect on quality of life in patients with hyposalivation. Intensity of dry mouth was lower after the applied therapy whatever substitute patients used.

Conclusions

We recommend the use of all three saliva substitutes for decreasing the intensity of dry mouth symptoms as well as improvement in the quality of life.

Clinical relevance

Although all tested agents showed beneficial effect in alleviating hyposalivation symptoms, it seems that Buccotherm® was superior to Xeros® and marshmallow root.
Literatur
1.
Zurück zum Zitat Tschoppe P, Wolgin M, Pischon N, Kielbassa AM (2010) Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 41:321–333PubMed Tschoppe P, Wolgin M, Pischon N, Kielbassa AM (2010) Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 41:321–333PubMed
2.
Zurück zum Zitat Fedele S, Wolff A, Strietzel FP, Martín-Granizo López R, Porter S, Konttinen YT (2010) Electrostimulation for the treatment of dry mouth. Harefuah 149(99–103):123 Fedele S, Wolff A, Strietzel FP, Martín-Granizo López R, Porter S, Konttinen YT (2010) Electrostimulation for the treatment of dry mouth. Harefuah 149(99–103):123
3.
Zurück zum Zitat Levine MJ, Aguirre A, Hatton MN, Tabak LA (1987) Artificial salivas: present and future. J Dent Res 66 Spec No:693-698 Levine MJ, Aguirre A, Hatton MN, Tabak LA (1987) Artificial salivas: present and future. J Dent Res 66 Spec No:693-698
4.
Zurück zum Zitat Kielbassa AM, Shohadai SP, Schulte-Mönting J (2001) Effect of saliva substitutes on mineral content of demineralized and sound dental enamel. Support Care Cancer 9:40–47CrossRefPubMed Kielbassa AM, Shohadai SP, Schulte-Mönting J (2001) Effect of saliva substitutes on mineral content of demineralized and sound dental enamel. Support Care Cancer 9:40–47CrossRefPubMed
6.
Zurück zum Zitat Wu-Wang CY, Patel M, Feng J, Milles M, Wang SL (1995) Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis. Arch Oral Biol 40:1093–1098CrossRefPubMed Wu-Wang CY, Patel M, Feng J, Milles M, Wang SL (1995) Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis. Arch Oral Biol 40:1093–1098CrossRefPubMed
7.
Zurück zum Zitat Femiano F, Rullo R, di Spirito F, Lanza A, Festa VM, Cirillo N (2011) A comparison of salivary substitutes versus natural sialogouge (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(1):e15–e20CrossRefPubMed Femiano F, Rullo R, di Spirito F, Lanza A, Festa VM, Cirillo N (2011) A comparison of salivary substitutes versus natural sialogouge (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(1):e15–e20CrossRefPubMed
8.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum, New Jersey Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum, New Jersey
9.
Zurück zum Zitat Oh DJ, Lee JY, Kim YK, Kho HS (2008) Effects of carboxymethylcellulose (CMC)-based artifical saliva in patients with xerostomia. Int J Oral Maxillofac Surg 37:1027–1031CrossRefPubMed Oh DJ, Lee JY, Kim YK, Kho HS (2008) Effects of carboxymethylcellulose (CMC)-based artifical saliva in patients with xerostomia. Int J Oral Maxillofac Surg 37:1027–1031CrossRefPubMed
10.
Zurück zum Zitat Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W (2007) Efficiacy of the BioXtra dry mouth care system in the treatement of radiotherapy-induced xerostomia. Support Care Cancer 15:1429–1436CrossRefPubMed Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W (2007) Efficiacy of the BioXtra dry mouth care system in the treatement of radiotherapy-induced xerostomia. Support Care Cancer 15:1429–1436CrossRefPubMed
11.
Zurück zum Zitat Rhodus NL, Bereuter J (2000) Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren’s syndrome. J Otolaryngol 29:28–34PubMed Rhodus NL, Bereuter J (2000) Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren’s syndrome. J Otolaryngol 29:28–34PubMed
12.
Zurück zum Zitat Gil-Montoya JA, Guardia-López I, Gonzáles-Moles MA (2008) Evaluation of the clinical efficiacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth—a pilot study. Gerodontology 25:3–9CrossRefPubMed Gil-Montoya JA, Guardia-López I, Gonzáles-Moles MA (2008) Evaluation of the clinical efficiacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth—a pilot study. Gerodontology 25:3–9CrossRefPubMed
13.
Zurück zum Zitat Aframian DJ, Mizrahi B, Granot I, Domb AJ (2010) Evaluation of a mucoadhesive lipid-based tablet compared with Biotène mouthwash for dry mouth relief—a pilot study. Quintessence Int 41:36–42 Aframian DJ, Mizrahi B, Granot I, Domb AJ (2010) Evaluation of a mucoadhesive lipid-based tablet compared with Biotène mouthwash for dry mouth relief—a pilot study. Quintessence Int 41:36–42
14.
Zurück zum Zitat Mouly SJ, Orler JB, Tillet Y, Coudert AC, Oberli F, Preshaw P et al (2007) Efficacy of a new lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. J Clin Psychopharmacol 27:437–443CrossRefPubMed Mouly SJ, Orler JB, Tillet Y, Coudert AC, Oberli F, Preshaw P et al (2007) Efficacy of a new lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. J Clin Psychopharmacol 27:437–443CrossRefPubMed
15.
Zurück zum Zitat Gómez-Moreno G, Guardia J, Aguilar-Salvatierra A, Cabrera-Ayala M, Maté-Sánchez de-Val JE, Calvo-Guirado JL (2013) Effectiveness of malic acid 1 % in patients with xerostomia induced by antihypertensive drugs. Med Oral Pathol Oral Cir Bucal 18:e49–e55CrossRef Gómez-Moreno G, Guardia J, Aguilar-Salvatierra A, Cabrera-Ayala M, Maté-Sánchez de-Val JE, Calvo-Guirado JL (2013) Effectiveness of malic acid 1 % in patients with xerostomia induced by antihypertensive drugs. Med Oral Pathol Oral Cir Bucal 18:e49–e55CrossRef
16.
Zurück zum Zitat Alpöz E, Güneri P, Onder G, Cankaya H, Kabasakal Y, Köse T (2008) The efficacy of Xialine in patients with Sjögren’s syndrome: a single-blind, cross-over study. Clin Oral Investig 12:165–172CrossRefPubMed Alpöz E, Güneri P, Onder G, Cankaya H, Kabasakal Y, Köse T (2008) The efficacy of Xialine in patients with Sjögren’s syndrome: a single-blind, cross-over study. Clin Oral Investig 12:165–172CrossRefPubMed
17.
Zurück zum Zitat Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1997) Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 11:225–232CrossRefPubMed Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1997) Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 11:225–232CrossRefPubMed
18.
Zurück zum Zitat Mouly S, Salom M, Tillet Y, Coudert AC, Oberli F, Preshaw PM et al (2007) Management of xerostomia in older patients: a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging 24:957–965CrossRefPubMed Mouly S, Salom M, Tillet Y, Coudert AC, Oberli F, Preshaw PM et al (2007) Management of xerostomia in older patients: a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging 24:957–965CrossRefPubMed
19.
Zurück zum Zitat Shirodaria S, Kilbourn T, Richardson M (2006) Subjective assessment of a new moisturizing mouth spray for the symptomatic relief of dry mouth. J Clin Dent 17:45–51PubMed Shirodaria S, Kilbourn T, Richardson M (2006) Subjective assessment of a new moisturizing mouth spray for the symptomatic relief of dry mouth. J Clin Dent 17:45–51PubMed
20.
Zurück zum Zitat Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM (2005) A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl) 14:319–326CrossRef Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM (2005) A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl) 14:319–326CrossRef
21.
Zurück zum Zitat Andersson G, Johansson G, Attström R, Edwardsson S, Glantz PO, Larsson (1995) Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 12:12–17CrossRefPubMed Andersson G, Johansson G, Attström R, Edwardsson S, Glantz PO, Larsson (1995) Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 12:12–17CrossRefPubMed
22.
Zurück zum Zitat Johansson G, Andersson G, Attström R, Glantz PO, Larsson K (1994) The effect of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology 11:46–49CrossRefPubMed Johansson G, Andersson G, Attström R, Glantz PO, Larsson K (1994) The effect of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology 11:46–49CrossRefPubMed
23.
Zurück zum Zitat Alpöz E, Cankaya H, Güneri P, Epstein JB, Boyacioglu H, Kabasakal Y et al (2014) Impact of Buccotherm® on xerostomia: a single blind study. Spec Care Dent. doi:10.1111/scd.12074 Alpöz E, Cankaya H, Güneri P, Epstein JB, Boyacioglu H, Kabasakal Y et al (2014) Impact of Buccotherm® on xerostomia: a single blind study. Spec Care Dent. doi:10.​1111/​scd.​12074
Metadaten
Titel
Comparison between three different saliva substitutes in patients with hyposalivation
verfasst von
Ivana Skrinjar
Vanja Vucicevic Boras
Iva Bakale
Ana Andabak Rogulj
Vlaho Brailo
Danica Vidovic Juras
Ivan Alajbeg
Danko Velimir Vrdoljak
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 3/2015
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-015-1405-8

Weitere Artikel der Ausgabe 3/2015

Clinical Oral Investigations 3/2015 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.